Successful rescue therapy with Raltegravir (MK-0518) and Etravirine (TMC125) in an hiv-infected patient failing all four classes of antiretroviral drugs.
Di Biagio
Antonio
A
Department of Infectious Diseases, University of Genoa, San Martino Hospital Genoa, Italy. antonio.dibiagio@hsanmartino.liguria.it
Bruzzone
Bianca
B
Rosso
Raffaella
R
Viganò
Ottavia
O
Icardi
Giancarlo
G
Viscoli
Claudio
C
Rusconi
Stefano
S
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000821:virology; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008297:Male; D009570:Nitriles; D009930:Organic Chemicals / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*; D011743:Pyrimidines; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D016879:Salvage Therapy; D016896:Treatment Outcome
D019380:Anti-HIV Agents; D009570:Nitriles; D009930:Organic Chemicals; D011724:Pyridazines; D011743:Pyrimidines; D011760:Pyrrolidinones; D018894:Reverse Transcriptase Inhibitors; C451734:etravirine; D000068898:Raltegravir Potassium